@article{2215e5e0fed8490eb21f795604d7c93a,
title = "An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis",
abstract = "Challenges intrinsic to the accurate diagnosis of endometriosis contribute to an extended delay between the onset of symptoms and clinical confirmation. Intraoperative visualization, preferably with histologic verification, is considered by many professional organizations to be the gold standard by which endometriosis is diagnosed. Clinical diagnosis of symptomatic endometriosis via patient history, physical examination, and noninvasive tests, though more easily executed, is generally viewed as less accurate than surgical diagnosis. Technological advances and increased understanding of the pathophysiology of endometriosis warrant continuing reevaluation of the standard method for diagnosing symptomatic disease. A review of the published literature was therefore performed with the goal of comparing the accuracy of clinical diagnostic measures with that of surgical diagnosis. The current body of evidence suggests that clinical diagnosis of symptomatic endometriosis is more reliable than previously recognized and that surgical diagnosis has limitations that could be underappreciated. Regardless of the methodology used, women with suspected symptomatic endometriosis would be well served by a diagnostic paradigm that is reliable, conveys minimal risk of under- or over-diagnosis, lessens the time from symptom development to diagnosis, and guides the appropriate use of medical and surgical management strategies.",
keywords = "Diagnosis, Endometriosis, Histology, Infertility, Laparoscopy, Pelvic examination, Pelvic pain, Surgery",
author = "Taylor, {Hugh S.} and Adamson, {G. David} and Diamond, {Michael Peter} and Goldstein, {Steven R.} and Horne, {Andrew W.} and Missmer, {Stacey A.} and Snabes, {Michael C.} and Eric Surrey and Taylor, {Robert N.}",
note = "Funding Information: HST has received research support from OvaScience and Pfizer and has served as a consultant for AbbVie, Bayer, OvaScience, ObsEva, Pfizer, and TherapeuD鸀cMsD. GDA has ownership in Advanced ReproducD鸀ve Care FerD鸄琀hitays, consulted for AbbVie, Bayer, Ferring, Guerbet, Hernest, Merck, and Ziva, and is President of the World Endometriosis Research FoundaD鸀onM. PD owns stock and serves on the Board of Directors of Advanced ReproducD鸀vCeare, and has received research support from AbbVie, Bayer, and ObsEva. SRG has served as a consultant for Philips Ultrasound, Cooper Surgical, and JDS TherapeuD鸀cs, and has parD鸀cipateind advisory boards for AbbVie, Allergan, AMAG PharmaceuD鸀calPs,fizer, Sermonix, Shionogi, and TherapeuD鸀cMs D. AWH receives research funding from the UK Medical Research Council, NaD鸀onaInl sD鸀tutfeor Health Research, and Wellbeing of Women, and is Chair of the European Society of Human ReproducD鸀on and Embryology Special Interest Group on Endometriosis and Funding Information: Medical wriD鸀nsgupport for development of this manuscript, funded by AbbVie Inc, was provided by Crystal Murcia and Lamara D Shrode of JB AshD鸀n. Publisher Copyright: {\textcopyright} 2018 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics",
year = "2018",
month = aug,
doi = "10.1002/ijgo.12521",
language = "English (US)",
volume = "142",
pages = "131--142",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "2",
}